Apidra 100IU/ml Solution for Injection
Marketer
Sanofi India Ltd
Salt Composition
Insulin Glulisine (100IU)
Overview Apidra 100IU/ml Solution for Injection
Insulin glulisine injection (Apidra 100 IU/mL) helps manage blood glucose in individuals with type 1 or type 2 diabetes. This rapid-acting insulin lowers post-meal blood sugar, mitigating the risk of diabetes-related complications. Apidra is typically used alongside a longer-acting insulin or other anti-diabetic medications. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Administer 15 minutes before or within 20 minutes of a meal. Discontinue only under your doctor's guidance. Successful treatment requires adherence to a prescribed diet, regular physical activity, and weight management as directed. Consistent blood glucose monitoring, recording, and sharing with your doctor are essential for dose optimization. Common adverse effects include low blood sugar (hypoglycemia), allergic reactions, injection site reactions, lipodystrophy, skin irritation, and upper respiratory infections. Preventing these requires accurate dosing, regular meals, and diligent blood sugar monitoring. Avoid use during hypoglycemic episodes. Inform your physician of any kidney, liver, or heart conditions prior to commencing treatment. Pregnant or lactating individuals should consult their doctor before using this medication.
Uses of Apidra 100IU/ml Solution for Injection
High blood sugar condition
Major Benefits of Apidra 100IU/ml Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Apidra 100IU/ml Solution for Injection:
- Hypoglycemia (low blood glucose level)
- Allergic reaction
- Injection site reactions (pain, swelling, redness)
- Lipodystrophy (skin thickening or pits at the injection site)
- Itching
- Rash
- Upper respiratory tract infection
How to use Apidra 100IU/ml Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
How Apidra 100IU/ml Solution for Injection works:
NovoLog FlexPen, a rapid-acting insulin solution (100 IU/mL), initiates its effects within 10 to 20 minutes post-injection. Its action mirrors that of naturally occurring insulin, promoting glucose absorption by muscle and adipose tissue while simultaneously suppressing hepatic glucose production.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Apidra 100 IU/mL Injection is not recommended due to safety concerns.
PregnancySAFE IF PRESCRIBED
Using Apidra 100 IU/ml Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; however, data from human studies are scarce.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Apidra 100 IU/ml injectable solution with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Individuals with kidney impairment should use Apidra 100 IU/ml injection cautiously. Dosage modification of Apidra 100 IU/ml injection may be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide dosage adjustments.
LiverCAUTION
Individuals with hepatic impairment should use Apidra 100 IU/mL injection cautiously; dosage modification may be necessary. Physician consultation is recommended. Close, consistent blood glucose monitoring is advised.
What if you forget to take Apidra 100IU/ml Solution for Injection :
Failure to administer a scheduled dose of Apidra 100 IU/mL injectable solution may result in elevated blood glucose (hyperglycemia). Monitor your blood sugar and adjust subsequent dosing as needed.
Facts to Know About Apidra 100IU/ml Solution for Injection
| Label | Value |
|---|---|
| Chemical Type | Modified insulin |
| Developing Habits | No. |
| Type of Treatment | Diabetes Medication |
| Actions | Fast-acting insulin analogs |



